Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    CRIGLER-NAJJAR SYNDROME, TYPE I
Show Display Options
Rank Status Study
1 Completed Orlistat Treatment of Crigler-Najjar Disease
Condition: Crigler-Najjar Syndrome
Intervention: Drug: orlistat
2 Completed Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)
Conditions: Urea Cycle Disorders,;   Crigler Najjar Syndrome
Intervention: Biological: HepaStem
3 Active, not recruiting New Phototherapy Device to Treat Patients With Crigler-Najjar Disease
Conditions: Crigler Najjar Syndrome;   Children
Interventions: Device: Arm1 homemade phototherapy treatment;   Device: DRAP
4 Recruiting Immunity Against AAV in Crigler Najjar Patient
Condition: Crigler Najjar Syndrome
Intervention: Biological: Blood sample for immunology
5 Active, not recruiting Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)
Conditions: Urea Cycle Disorders,;   Crigler Najjar Syndrome
6 Unknown  Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome
Condition: Levator Ani Syndrome With Pain and/or Constipation Symptoms.
Interventions: Behavioral: Biofeedback therapy;   Procedure: Botulinum Toxin Type A Injection
7 Suspended Hepatocyte Transplantation for Liver Based Metabolic Disorders
Condition: Metabolic Diseases
Interventions: Drug: human hepatocyte transplantation;   Radiation: Preparative Radiation Therapy

Indicates status has not been verified in more than two years